Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women

10.1016/s0140-6736(98)04394-3 ◽

1998 ◽

Vol 352 (9145) ◽

pp. 93-97 ◽

Author(s):

U Veronesi

Keyword(s):

Breast Cancer ◽

Randomised Trial ◽

Prevention Of Breast Cancer

Download Full-text

A randomised trial of zoladex plus raloxifene plus screening versus screening alone for the prevention of breast cancer in premenopausal women at high genetic risk

http://isrctn.org/> ◽

10.1186/isrctn17775670 ◽

2013 ◽

Author(s):

Anthony Howell

Keyword(s):

Breast Cancer ◽

Genetic Risk ◽

Randomised Trial ◽

Premenopausal Women ◽

High Genetic Risk ◽

Prevention Of Breast Cancer

Download Full-text

Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women

10.1016/s0140-6736(98)85011-3 ◽

1998 ◽

Vol 352 (9122) ◽

pp. 93-97 ◽

Author(s):

U Veronesi ◽

P Maisonneuve ◽

A Costa ◽

V Sacchini ◽

C Maltoni ◽

...

Keyword(s):

Breast Cancer ◽

Randomised Trial ◽

Prevention Of Breast Cancer

Download Full-text

The prevention of breast cancer induction by plant extracts and the postradiation alterations of DNA structure

European Journal of Cancer ◽

10.1016/s0959-8049(02)80389-6 ◽

2002 ◽

Vol 38 (11) ◽

pp. S119 ◽

Author(s):

S Ivanov

Keyword(s):

Breast Cancer ◽

Plant Extracts ◽

Dna Structure ◽

Cancer Induction ◽

Prevention Of Breast Cancer

Download Full-text

Exercise-based Cardiac Rehabilitation for the Prevention of Breast Cancer Chemotherapy-induced Cardiotoxicity

Case Medical Research ◽

10.31525/ct1-nct03964142 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Cardiac Rehabilitation ◽

Cancer Chemotherapy ◽

Breast Cancer Chemotherapy ◽

Prevention Of Breast Cancer

Download Full-text

Faculty Opinions recommendation of The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1104781.560855 ◽

2008 ◽

Author(s):

Jean-Claude Horiot

Keyword(s):

Breast Cancer ◽

Early Breast Cancer ◽

Randomised Trial ◽

Breast Radiotherapy ◽

Start Trial ◽

Download Full-text

Faculty Opinions recommendation of Meta-analysis of vitamin D, calcium and the prevention of breast cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1168050.630163 ◽

2009 ◽

Author(s):

Suzanne C Ho ◽

Roselle Lee

Keyword(s):

Breast Cancer ◽

Vitamin D ◽

Meta Analysis ◽

Prevention Of Breast Cancer

Download Full-text

Faculty Opinions recommendation of Subcutaneous versus intravenous administration of (neo)adjuvant trastuzumab in patients with HER2-positive, clinical stage I-III breast cancer (HannaH study): a phase 3, open-label, multicentre, randomised trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717955064.793462779 ◽

2012 ◽

Author(s):

Nancy Lin ◽

Ines Vaz-Luis

Keyword(s):

Breast Cancer ◽

Intravenous Administration ◽

Clinical Stage ◽

Randomised Trial ◽

Stage I ◽

Her2 Positive ◽

Phase 3 ◽

Adjuvant Trastuzumab

Download Full-text

Faculty Opinions recommendation of Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717969556.793525549 ◽

2016 ◽

Author(s):

Daniel Vorobiof

Keyword(s):

Breast Cancer ◽

Oestrogen Receptor ◽

Randomised Trial ◽

Adjuvant Tamoxifen ◽

Long Term Effects ◽

Positive Breast Cancer

Download Full-text

Faculty Opinions recommendation of Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717969556.793480576 ◽

2013 ◽

Author(s):

Nancy Lin ◽

Ines Vaz-Luis

Keyword(s):

Breast Cancer ◽

Oestrogen Receptor ◽

Randomised Trial ◽

Adjuvant Tamoxifen ◽

Long Term Effects ◽

Positive Breast Cancer

Download Full-text

Faculty Opinions recommendation of Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718206879.793509584 ◽

2015 ◽

Author(s):

Pagona Lagiou

Keyword(s):

Breast Cancer ◽

High Risk ◽

Postmenopausal Women ◽

Controlled Trial ◽

Double Blind ◽

Prevention Of Breast Cancer

Download Full-text